Summary of Significant Accounting Policies - Additional Information (Details)			3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 25, 2024 USD ($)	Jun. 19, 2024 shares	Sep. 30, 2024 USD ($) Customer	Sep. 30, 2023 USD ($) Customer	Sep. 30, 2024 USD ($) Segment Customer	Sep. 30, 2023 USD ($) Customer	Dec. 31, 2023 USD ($) Segment Customer shares
Summary Of Significant Accounting Policies [Line Items]
Restricted cash			$ 100,000		$ 100,000		$ 0
Impairment loss			0		0
Impairment of available-for-sale debt securities			10,073,000		$ 10,073,000
Number of reporting segments | Segment					2		1
Contract with customer liability, revenue recognized			800,000	$ 700,000	$ 1,600,000	$ 2,200,000
Reclassification from other comprehensive income (loss)			2,700,000		3,500,000
Redeemable preferred stock investment							$ 20,438,000
Redeemable preferred stock investment shares held | shares							7,300,000
Shares received in connection with Helio Genomics | shares		7,300,000
Unrealized holding gains	$ 400,000
Preferred stock, value
Tax effect of adjustments recognized as benefit					2,100,000
Tax effects related to unrealized holding gain on available-for-sale debt securities			0	1,200,000	0	2,400,000
Variable consideration			0	$ 18,900,000	1,800,000	$ 18,900,000
Contract assets			$ 0		$ 0		$ 0
Boston Molecules, Inc.
Summary Of Significant Accounting Policies [Line Items]
Ownership percentage			25.00%		25.00%
Carrying value of equity			$ 0		$ 0
Insurance Customer
Summary Of Significant Accounting Policies [Line Items]
Percentage of net accounts receivable from contract			53.00%		53.00%		39.00%
Institutional Customer
Summary Of Significant Accounting Policies [Line Items]
Percentage of net accounts receivable from contract			47.00%		47.00%		61.00%
Customer Concentration Risk | Revenue | Customer One
Summary Of Significant Accounting Policies [Line Items]
Number of customers | Customer			1	1	1	1
Revenues			$ 16,200,000	$ 12,200,000	$ 45,700,000	$ 24,800,000
Concentration risk, percentage			23.00%	14.00%	22.00%	11.00%
Customer Concentration Risk | Accounts Receivable | Customer One
Summary Of Significant Accounting Policies [Line Items]
Number of customers | Customer					1		1
Concentration risk, percentage					10.00%		13.00%
Minimum
Summary Of Significant Accounting Policies [Line Items]
Intangible asset, useful life			3 years		3 years
Maximum
Summary Of Significant Accounting Policies [Line Items]
Intangible asset, useful life			14 years		14 years
Other Long-Term Assets
Summary Of Significant Accounting Policies [Line Items]
Preferred stock, value	$ 9,900,000